147 related articles for article (PubMed ID: 18286573)
21. Semispecific TPPII inhibitor Ala-Ala-Phe-chloromethylketone (AAF-cmk) displays cytotoxic activity by induction of apoptosis, autophagy and protein aggregation in U937 cells.
Bialy LP; Fayet J; Wilczynski GM; Mlynarczuk-Bialy I
Folia Histochem Cytobiol; 2018; 56(4):185-194. PubMed ID: 30294774
[TBL] [Abstract][Full Text] [Related]
22. Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins.
Marcilla M; Cragnolini JJ; López de Castro JA
Mol Cell Proteomics; 2007 May; 6(5):923-38. PubMed ID: 17308301
[TBL] [Abstract][Full Text] [Related]
23. Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope.
Wherry EJ; Golovina TN; Morrison SE; Sinnathamby G; McElhaugh MJ; Shockey DC; Eisenlohr LC
J Immunol; 2006 Feb; 176(4):2249-61. PubMed ID: 16455981
[TBL] [Abstract][Full Text] [Related]
24. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases.
Lévy F; Burri L; Morel S; Peitrequin AL; Lévy N; Bachi A; Hellman U; Van den Eynde BJ; Servis C
J Immunol; 2002 Oct; 169(8):4161-71. PubMed ID: 12370345
[TBL] [Abstract][Full Text] [Related]
25. Analysis of direct and cross-presentation of antigens in TPPII knockout mice.
Firat E; Huai J; Saveanu L; Gaedicke S; Aichele P; Eichmann K; van Endert P; Niedermann G
J Immunol; 2007 Dec; 179(12):8137-45. PubMed ID: 18056356
[TBL] [Abstract][Full Text] [Related]
26. Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells.
Zhang J; Wong J; Gao G; Luo H
FEBS Lett; 2011 Jan; 585(1):261-5. PubMed ID: 21134372
[TBL] [Abstract][Full Text] [Related]
27. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
[TBL] [Abstract][Full Text] [Related]
28. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells.
Bury M; Młynarczuk I; Pleban E; Hoser G; Kawiak J; Wójcik C
Folia Histochem Cytobiol; 2001; 39(2):131-2. PubMed ID: 11374791
[TBL] [Abstract][Full Text] [Related]
29. In situ structural studies of tripeptidyl peptidase II (TPPII) reveal spatial association with proteasomes.
Fukuda Y; Beck F; Plitzko JM; Baumeister W
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4412-4417. PubMed ID: 28396430
[TBL] [Abstract][Full Text] [Related]
30. A role for nuclear translocation of tripeptidyl-peptidase II in reactive oxygen species-dependent DNA damage responses.
Preta G; de Klark R; Glas R
Biochem Biophys Res Commun; 2009 Nov; 389(4):575-9. PubMed ID: 19747897
[TBL] [Abstract][Full Text] [Related]
31. Proteasomes get by with lots of help from their friends.
Yewdell JW; Princiotta MF
Immunity; 2004 Apr; 20(4):362-3. PubMed ID: 15084265
[TBL] [Abstract][Full Text] [Related]
32. Is there an alternative to the proteasome in cytosolic protein degradation?
Antón LC; Villasevil EM
Biochem Soc Trans; 2008 Oct; 36(Pt 5):839-42. PubMed ID: 18793147
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles.
Breslin HJ; Miskowski TA; Kukla MJ; Leister WH; De Winter HL; Gauthier DA; Somers MV; Peeters DC; Roevens PW
J Med Chem; 2002 Nov; 45(24):5303-10. PubMed ID: 12431057
[TBL] [Abstract][Full Text] [Related]
34. Post-proteasomal and proteasome-independent generation of MHC class I ligands.
van Endert P
Cell Mol Life Sci; 2011 May; 68(9):1553-67. PubMed ID: 21390545
[TBL] [Abstract][Full Text] [Related]
35. Tripeptidyl peptidase II. An oligomeric protease complex from Arabidopsis.
Book AJ; Yang P; Scalf M; Smith LM; Vierstra RD
Plant Physiol; 2005 Jun; 138(2):1046-57. PubMed ID: 15908606
[TBL] [Abstract][Full Text] [Related]
36. Tripeptidyl-peptidase II controls DNA damage responses and in vivo gamma-irradiation resistance of tumors.
Hong X; Lei L; Künert B; Naredla R; Applequist SE; Grandien A; Glas R
Cancer Res; 2007 Aug; 67(15):7165-74. PubMed ID: 17671184
[TBL] [Abstract][Full Text] [Related]
37. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization.
Firat E; Tsurumi C; Gaedicke S; Huai J; Niedermann G
Cancer Res; 2009 Apr; 69(8):3325-31. PubMed ID: 19351849
[TBL] [Abstract][Full Text] [Related]
38. Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation.
Saveanu L; Carroll O; Hassainya Y; van Endert P
Immunol Rev; 2005 Oct; 207():42-59. PubMed ID: 16181326
[TBL] [Abstract][Full Text] [Related]
39. Tripeptidyl-peptidase II: a multi-purpose peptidase.
Tomkinson B; Lindås AC
Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
[TBL] [Abstract][Full Text] [Related]
40. MAP kinase-signaling controls nuclear translocation of tripeptidyl-peptidase II in response to DNA damage and oxidative stress.
Preta G; de Klark R; Chakraborti S; Glas R
Biochem Biophys Res Commun; 2010 Aug; 399(3):324-30. PubMed ID: 20643100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]